Skip to content
Top Menu
  • Subscribe Newsletter
  • 中文
GeneOnline News

GeneOnline News

The Next Generation Biotech Media

MENUMENU
  • Home
  • COVID-19
  • Topics
        • Asia Insight
        • Latest News
        • North America
        • International
  • Technology
  • Feature
  • Industry News
  • BIO Asia-Taiwan
  • Interview
  • Event
  • linkedin

Tag: immunotherapy

Asia Insight

China’s Adagene Gears Up for IPO, Seeking 125 Million for Cancer Therapy Development

2021-01-24 - by Tyler Chen - Leave a Comment

Targeting up to 125 million, China’s cancer immunotherapy developer Adagene filed for IPO on January 19th and will later list on the Nasdaq. Based in Suzhou, China, Adagene is leveraging …

Read More
Asia Insight / Deals

Novartis Fortifies Immuno-Oncology Franchise with BeiGene Collaboration

2021-01-142021-01-15 - by GeneOnline - Leave a Comment

In recent times, several big pharma have collaborated with small companies in the immuno-oncology field. Last September, Pfizer made a $200 million investment to collaborate with CStone Pharmaceuticals. Now Novartis …

Read More
Asia Insight / Investment

China’s Gracell Biotechnologies, a CAR-T Therapy Company, Targets 150 Million for IPO

2021-01-12 - by Tyler Chen - Leave a Comment

On January 4th, China-based biotech Gracell Biotechnologies (Gracell) revealed details of the IPO. Gracell is offering 8.8 million American depositary shares (ADS) with 16 to 18 apiece, which will result …

Read More
Event / Feature

Kite Presents Yescarta’s Encouraging Long Term ZUMA-1 Trial Results at ASH2020

2020-12-062020-12-06 - by GeneOnline - Leave a Comment

On December 5th, Kite Pharma, a Gilead Company, announced their 4-year follow-up data from the monumental clinical trial ZUMA-1, which tested the efficacy and safety of their CAR-T cell therapy, …

Read More
Feature

Spotlight: Cholesterol Reducing Drugs Could Potentially Augment Cancer Immunotherapy

2020-11-22 - by GeneOnline - Leave a Comment

A new study published in the journal Nature on November 11th shows the importance of cholesterol metabolizing protein in cancer immunotherapy. The group reported that by downregulating PCSK9, a protein …

Read More
Asia Insight

Aiming for the First CAR-T Approval in China, JW Therapeutics Debuts on Hong Kong Stock Exchange

2020-11-042020-11-04 - by GeneOnline - Leave a Comment

By Tyler Chen On November 3rd, China-based cell therapy company JW Therapeutics launched a 300 million IPO on the main board of the Hong Kong stock exchange. JW is a …

Read More
Industry News

With their Respective Immunotherapy Drugs, Arcus, AstraZeneca Combine to Combat Lung Cancer

2020-10-312020-10-31 - by GeneOnline - Leave a Comment

By Daniel Ojeda, Ph.D. On October 29th, Arcus Biosciences announced a collaboration with AstraZeneca to conduct Phase 3 clinical trial to determine the efficacy of Domvanalimab (AB154) treatment in combination …

Read More
Asia Insight

Biotech Duo Revise Co-development & Commercialization Agreement of Intelligent Drug Delivery System

2020-10-072020-10-07 - by GeneOnline - Leave a Comment

By Judy Ya-Hsuan Lin Cancerous tumors create highly specific conditions in their growth environment that are not present in normal tissues. Their established specificity allows researchers to develop safer therapeutic …

Read More
Asia Insight

China-Based Immunotherapy Company Receives FDA’s Orphan Drug Designation for Advanced Gastric Cancer Treatment

2020-10-062020-10-06 - by GeneOnline - Leave a Comment

By Judy Ya-Hsuan Lin Gastric cancer ranks top three in cancer-related mortality and is considered one of the most incurable cancers worldwide. Patients with gastric and gastroesophageal junction cancer type …

Read More
North America

FDA Approves Treatment for Aggressive Form of Mesothelioma After Sixteen Long Years

2020-10-042020-10-04 - by GeneOnline - Leave a Comment

By Rajaneesh K. Gopinath, Ph.D. Mesothelioma, a rare form of cancer, occurs in the mesothelium, a thin membrane that lines the heart, lungs, stomach, and other internal organs. Primarily caused …

Read More

Posts navigation

1 2 … 5 Next

TODAY IN HISTORY

June 28, 2004: NHGRI Established Centers of Exellence in Genomic Science at Havard and Johns Hopkins University
Today In History
June 28, 2004: NHGRI Established Centers of Exellence in Genomic Science at Havard and Johns Hopkins University
2018-06-29
Tweets by GeneOnlineNews
  • Home
  • Feature
  • Technology
  • Industry News
  • Event
  • Topics
    • COVID-19
    • Asia Insight
    • International
    • Latest News
    • North America

MEDIA INQUIRIES

service@geneolineasia.com

website

Chinese
Copyright © 2021 GeneOnline News.
Powered by WordPress and HitMag.

[pie_register_login]